Background BardeteBiedl syndrome is a pleiotropic disorder with 14 BBS genes identified. BBS1, BBS2, BBS4, BBS5, BBS7, BBS8, and BBS9 form a complex called the BBSome, which is believed to recruit Rab8 GTP to the primary cilium and promote ciliogenesis. The second group, the chaperonin-like proteins BBS6, BBS10, and BBS12, have been defined as a vertebrate-specific branch of the type II chaperonin superfamily. These may play a role in the regulation of BBSome assembly. Methods and results Using sequence analysis, the role of BBS6, 10 and 12 was assessed in the patient population comprising 93 cases from 74 families. Systemic and ocular phenotypes were defined. In the study, chaperonin-like BBS gene mutations accounted for the disease in approximately 36.5% of BBS families. A total of 38 different non-polymorphic exonic sequence variants were identified in 40.5% of BBS families (41.9% cases), of which 26 were novel (68%). Six cases had mutations present in more than one chaperonin-like BBS gene. One case with four mutations in BBS10 had a phenotype of overall greater severity. The phenotypes observed were beyond the classic BBS phenotype as they overlapped with characteristics of MKKS (congenital heart defect, vaginal atresia, hydrometrocolpos, cryptorchidism), as well as Alström syndrome (diabetes, hearing loss, liver abnormalities, endocrine anomalies, cardiomyopathy). Conclusions While overlap between the MKKS and BBS phenotypes has previously been reported for cases with BBS6 mutations, we also observed MKKS phenotypes involving BBS10 and BBS12 and Alström-like phenotypes associated with mutations in BBS1, BBS2, BBS6, BBS7, BBS9, BBS10 and BBS12 for the first time.
INTRODUCTION
BardeteBiedl syndrome (BBS; MIM 209900) is a genetically heterogeneous, pleiotropic ciliopathy disorder characterised by retinal degeneration, obesity, polydactyly, renal abnormalities, hypogonadism, and cognitive impairment. The 14 BBS genes identified (BBS1 to BBS14) account for approximately 70% of affected families. 1 2 The new knowledge that BBS proteins are important for biogenesis and maintenance of the cilium explains the pleiotropy of this condition. 3 4 Genetic and clinical phenotype overlaps with other ciliopathies, such as McKusick Kaufman syndrome (MKKS, BBS6; MIM604896), Alström syndrome (ALMS, MIM203800) and Meckel Gruber syndrome (MKS; MIM 249000, 603294, 607361, 611134), have been described. 1 5e9 These allelic variants can lead to very different clinical entities. For example, mutations in the MKKS (BBS6) gene result in a MKKS phenotype (hydrometrocolpos, cardiac malformation), a BBS phenotype or a combination of both.
Most of the BBS proteins can be broken into two groups. BBS1, BBS2, BBS4, BBS5, BBS7, BBS8, and BBS9 form a complex called the BBSome which is believed to recruit Rab8 GTP to enter the primary cilium and promote ciliogenesis. 4 The second group, the chaperonin-like proteins including BBS6, BBS10, and BBS12, are a part of rapidly evolving, vertebrate specific branch of the type II chaperonin superfamily.
2 BBS6 was shown to shuttle rapidly between the centrosome and the cytosol, 10 and to be important for cytokinesis, 11 while the BBS10 and BBS12 proteins, seen within the basal body of the primary cilium of differentiating preadipocytes, are important for ciliogenesis and adipogenesis. 12 As the function of these chaperonin-like proteins is being elucidated, these are proposed to play a role in the regulation of BBSome assembly. 13 As part of a larger scale project of mutational analysis of BBS genes, we present here the role of type II chaperonin-like BBS genes in our patients of diverse ancestral background. Mutations in BBS6, BBS10, and BBS12 were disease causing in 36.5% of BBS families and the overlapping phenotypes of MKKS and Alström were seen in several of these patients.
SUBJECTS AND METHODS Patient recruitment
The Hospital for Sick Children Research Ethics Board approved this study, which respected the tenets of the Declaration of Helsinki. The patient cohort of 74 families (93 cases) was of multiethnic origin and recruited from The Hospital for Sick Children in Toronto and from collaborators abroad (Spain, USA, South Africa). Diagnosis of BBS was based on the presentation of four of the six primary features including retinitis pigmentosa, polydactyly, obesity, cognitive impairment, genital abnormalities and/or renal failure, or three primary plus two secondary features.
14 < Supplementary tables are published online only.To view these files please visit the journal online (http://jmg.bmj. com).
Phenotype characterisation
Participants were evaluated for systemic and ocular features of BBS as much as possible. Systemic evaluation documented body mass index (BMI), physical developmental abnormalities, assessment of cognitive impairment/developmental delay, genital abnormalities, lipid profile, and liver and kidney function tests. Ocular phenotypes were defined using a comprehensive ocular exam, kinetic perimetry, full field electroretinography (ERG), and ocular coherence tomography (OCT).
Mutational analysis
Genomic DNA was isolated using standard protocols. Coding exons and flanking intronic regions of BBS6 (RefSeq NM_018848), BBS10 (RefSeq NM _024685.3) and BBS12 (RefSeq NM_152618.2) were PCR amplified from 50 ng of genomic DNA in Dr Héon's laboratory. Samples were directly sequenced by The Centre for Applied Genomics (TCAG, Toronto, Ontario, USA) or by the McGill University and Génome Québec Innovation Centre (Montreal, Quebec, Canada). Sequence changes observed were confirmed on both sense and antisense DNA strands. Primers and conditions are available upon request. Segregation analysis of observed variants was performed when possible. The allele frequency of novel mutations was assessed in at least 300 control chromosomes (from the Héon Lab, Coriell Caucasian Human Variation PaneldTCAG, HapMap Yoruba/YRIdPaterson Lab and Cree, Ojibway, InuitdHegele Lab) using either amplification refractory mutation system (ARMS) assays, restriction enzyme digests, or heteroduplex analysis. Specific ethnic backgrounds were evaluated when available. Novel mutations were evaluated for predicted potential effects on splicing, destruction or creation of exonic splicing enhancers (ESEs), and interspecies conservation using a variety of publicly available software. PolyPhen analysis was used to predict whether missense mutations could impact the protein structure and function. Protein modelling is discussed below. Web resources used are listed at the end of the article and in supplementary table 1.
Potential pathogenicity was based on positive family segregation, an allele frequency of <1/300 chromosomes, and bioinformatic prediction of biological significance. Changes discussed are non-polymorphic (allele frequency <1%). Some changes discussed are of unclear pathogenicity.
Protein modelling
To gain insight into the effects of the missense mutations identified, models of BBS6, BBS10, and BBS12 were built using homology modelling techniques. These three proteins closely resemble the group II chaperonin a subunit, sharing the same three domain structures: equatorial, intermediate, and apical. The protein sequences were extracted from the RefSeq resource of NCBI (accession number NP_061336, NP_078961.3, NP_689831.2). A search using pfam and blast with default options identified three structures deposited in the Protein Data Bank (PDB) 15 : a group II chaperonin structure (PDB RCSB code 1q2v) , Cpn60 (1we3) and Thermosome (1a6d). All three had low sequence identity (15e23%) to the BBS6/10/12 proteins. The group II chaperonin protein (1q2v) was the closest related (21% to BBS6; 17% to BBS10; 16% to BBS12), and was used as the main template. The BBS protein sequences were aligned to the template protein using NW alignment 16 and gaps in the sequences corresponding to a-helices and b-strands were manually displaced towards positions in loop regions. The main chain atoms in the BBS proteins were assigned the spatial coordinates of equivalent residues in the 1q2v template. The conformations of the side chains were built onto the BBS model backbone using a Metropolis Monte Carlo procedure implemented in the software Modzinger (Ogata, Leplea, Wodak, unpublished). Despite the very low sequence homology between the BBS proteins and the available templates, these models were guides for missense mutations that could be mapped onto the three conserved domains. Modelling the effects of these mutations was done by searching for optimal side chain positions within the core of the constructed BBS structures.
RESULTS

Mutational analysis
Thirty-eight non-polymorphic sequence variants were identified. Twenty-six (68%) were novel and summarised in 
BBS6 mutations
Four of the six different BBS6 mutations identified were novel (table 1). Three of these (G41R, C99R, and P299L) affected highly conserved residues, were predicted to destroy potential ESE sites, and were predicted to be 'probably damaging' by PolyPhen (supplementary table 1). The mutation of case 46 (F94SfsX9) was previously published 7 but phenotype data are presented for the first time. The phenotypes of cases 11 and 46 show an overlap with the ALMS phenotype and an MKKS phenotype (table 2) .
Heterozygous BBS6 changes were seen in three unrelated patients (cases 30, 80 and 38, table 1) for whom the 'principal mutation' also involved a chaperonin-like BBS gene. The epistatic effect of BBS6 A242S 17 18 in case 80 (vs sib case 79) could not be assessed. The BBS6 A488T (case 38) variant was associated with mutations in BBS9 and BBS12 in a child with a mixed BBS/MKKS phenotype having hydrometrocolpos and congenital heart disease.
BBS10 mutations
Ten of the 18 different BBS10 mutations identified were novel. Nineteen cases (16 families) had homozygous or compound heterozygous BBS10 changes (table 1) .
Affected sibs of South African descent (cases 65 and 66) carried the novel L55P and E274VfsX29 mutations that segregated with the disease phenotype (figure 2a). The variant E274VfsX29, if translated, would be missing 62% of the native protein ( figure 1 ) with the addition of 28 novel amino acids. These sibs also carried BBS12 mutations (discussed below). Only case 66 had cryptorchidism and abnormal liver function, features that are part of the MKKS and ALMS phenotype, respectively.
Case 60, of Turkish descent, was homozygous for two novel changes that segregated in cis; K188T and A636V (figure 2b). It remains unclear whether both or only one of the changes were necessary to produce the disease phenotype. The additional novel heterozygous changes (BBS1 (I389I); BBS12 (T501T)) in this patient were predicted to be non-pathogenic. Her phenotype (table 2) was more severe than usual with prematurity (34 weeks gestation), small for age (1615 g), cystic kidney degeneration, hexadactily and syndactyly of two limbs, a bicuspid and stenotic aortic valve and dysmorphism. Dental crowding, psychomotor retardation, and her non-recordable ERG at the age of 4 years were documented.
As previously published, C91LfsX5 was the most common pathogenic change observed in BBS10. 19 This mutation accounted for 25.7% of our BBS10 changes. Probands 20, 30 and 79 of unrelated European ancestry were compound heterozygous, with one copy of this C91LfsX5 mutation 19 and a novel E104KfsX7, Y559X or H410Q change, respectively. These changes segregated with the disease phenotype (data not shown). The variant E104KfsX7, if translated, would be missing 86% of the native protein with the addition of six novel amino acids, while Y559X would be missing 23% of the native protein at the C-terminus. Whether patients were homozygous or compound heterozygous made no difference in terms of phenotype severity. Homozygous patients (eg, cases 63 and 83) showed phenotype differences (eg, kidney and liver function), highlighting the complexity of this condition. Screening of BBS2, BBS3, BBS4, BBS5, BBS7, BBS8, and BBS11 was not completed for all patients.
[¼] refers to a wild-type allele. Families: *04e14; y07e08; z07e04; x99e12; {03e10; **03e02. CNI, Canadian Native Indian (Dene).
Three unrelated cases (43, 47, and 86) carried only one heterozygous BBS10 mutation (A296T, H715R and H415H, respectively). Case 43 was also compound heterozygous for BBS1; M390R and M242RfsX83 (if translated, would be missing 59% of the native protein with the addition of 82 novel amino acids). Case 47 (consanguineous family) was homozygous for BBS1 I296TfsX7 which, if translated, would be missing 50% of the native protein with the addition of six novel amino acids. Case 86 has not yet had the primary mutations identified.
BBS12 mutations
Twelve of the 14 different BBS12 mutations identified were novel. Ten cases (seven families) were either homozygous or compound heterozygous for changes in BBS12. An affected sib pair (cases 65 and 66) had heterozygous BBS12 changes (G119S; Y263H) in addition to their two 'primary' BBS10 disease-causing mutations. Family segregation suggested that both BBS12 mutations were located on the maternally inherited allele with no phenotype association (figure 2a).
Cases 2 and 3 (family 99-12) were homozygous for two novel missense changes V400M and R674C in cis, with an additional heterozygous F534A mutation in BBS1 (figure 2c). They showed phenotypes overlapping with MKKS and ALMS (non-alcoholic steatohepatitis, gynaecomasty, asthma, cryptorchidism, scoliosis, osteopenia, gum disease and endocrine anomalies).
Case 38 with a combined BBS/MKKS phenotype (table 2) carried compound heterozygous disease-causing changes in BBS12 (T501M 2 and R525H; novel), a heterozygous novel BBS6 A488T variant (discussed above) in addition to two novel heterozygous BBS9 changes (T549I, L665F). As the family or RNA from the patient were not available, sequencing of single alleles (details available upon request) showed the BBS12 mutations were located on separate alleles. In addition to polydactyly of two limbs, she was diagnosed with congenital heart disease, genitourinary sinus anomalies and distal vaginal stenosis with secondary hydrocolpos and hydronephrosis at birth. An ERG documented a severe rodecone dysfunction by the age of 4 years. Her visual acuity at that time was normal for her age despite her mild developmental delay (tables 2 and 3).
Case 52 was homozygous for a novel nonsense S35X mutation which, if translated, would be missing 95% of the native protein (figure 1). His phenotype overlaps with that of ALMS with features of diabetes and hearing loss, in addition to those of BBS.
Affected sibs 24 and 56 (consanguineous family 3e10) were homozygous for the novel truncating frameshift D480MfsX3 which could cause the loss of 33% of the native protein and add two novel amino acids. Both sibs also carried a novel heterozygous BBS4 variant (T488K) and, despite having the same variants, show phenotype variability. Case 24 had a phenotype overlapping with MKKS with vaginal atresia and urogenital sinus malformation, which was not documented for case 56.
Case 88 was compound heterozygous for the previously published P632FfsX7 2 variant and a novel missense mutation G539D. His phenotype overlapped ALMS (table 2) .
Case 89 carried two novel mutations, The novel frameshift mutation N461KfsX10 of case 89 mutation would cause the loss of 35% of the native protein and the addition of nine novel amino acids. The accompanying novel L88 is a highly conserved residue in the N-terminus equatorial domain. The phenotype of this patient included features of MKKS and ALMS in addition to BBS.
BBS12 R355Q
A large Canadian Native Indian family carried three novel variants; BBS2 (L125R), BBS4 (E61K) and BBS12 (R355Q) ( figure 3 ). This family of Dene origin is from an isolated, presumed consanguineous, community in the North West Territories (NWT).
The BBS12 c.1064 G/A, R355Q variant altered a conserved residue and was not observed in 110 control chromosomes of No other BBS variants were identified in him, unlike for case 126 (proband), homozygous for BBS12 R355Q and also heterozygous for BBS2 and BBS4 variants with a BBS phenotype (see below and figure 3) , that included cardiac malformation requiring open heart surgery in addition to the more classis features of polydactyly (two limbs), overweight, developmental delay, and night blindness with a dystrophic looking retina (ERG and fundus photography were not yet available). Whether this represents a case of oligogenic influence or not will remain unanswered as case 128 cannot be found for further investigation. Overweight and obesity were defined with criteria of the Centers for Disease Control. When body mass index was not available, the presence of an obvious weight phenotype was accepted. Families: *04e14; y07e08; z07e04; x99e12; {03e10; **03e02. yyThis child was also known to be small for age and premature (34 gestational weeks ; 1615 g), had a bicuspid and stenotic aortic valves, dysmorphic facies, dental crowding and psychomotor retardation. + Present; e not present; blank NA. Abn, abnormal; DA, digit anomaly; CI, cognitive impairment (+:mild, ++:moderate, +++:severe); DD, developmental delay; Gnds, gonadal anomalies documented; HTrans, high transaminases; Lstr, liver structure abnormal; RD, retinal dystrophy; Rfx/str, anomalies of renal function and structure; W, weight anomalies such as obesity/overweight.
Family 03-02 also had five other affected individuals homozygous for BBS2 L125R (table 1, figure 3 ). This novel variant was not seen in 370 control chromosomes of mixed ethnic background. Its allele frequency was 0.055 (13/236 chromosomes) locally and 0.0103 (13/1260 chromosomes) in controls of Cree origin. Three of those patients with a classic BBS phenotype were also heterozygous for BBS4 E61K and BBS12 R355Q.
Although BBS4 E61 is a conserved residue, this variant was homozygous in one examined unaffected individual of family 03-02. E61K was not seen in 100 control chromosomes of mixed ethnic background. The E61K allele frequency was 0.0033 (3/904 chromosomes) in Cree Native Indians and 0.172 (20/116 chromosomes) in the Dene population.
Protein modelling
Three potential tertiary structure templates of related proteins were used to model the novel BBS6, BBS10 and BBS12 proteins: a group II chaperonin structure (PDB RCSB code 1q2v), Cpn60 (1we3), and Thermosome (1a6d). All showed very low sequence homology with BBS proteins, but featured the three main domains: equatorial, intermediate, and apical. An overlay of these three structures revealed notable differences in tertiary structure, particularly in the apical domain. Furthermore, residues that were highly conserved across species for the BBS proteins were not necessarily conserved in the type II chaperonins. The resulting protein models would not allow reliable predictions on the biological significance of many missense mutations identified. For example, BBS6 P299, BBS10 A296, BBS12 R355 and V400 were all located in the apical domain (figure 1), which showed considerable variability in conformation across the group II chaperonin a subunits. BBS6 A488, and BBS10 H410 and H715 were located in protein segments that had no equivalent in the selected templates. BBS12 V400 was not conserved within the chaperonins.
In contrast, predictions could be made for mutations occurring in the equatorial domain, which is primarily a-helical with a highly conserved structure. BBS6 G41 was located in a loop between the a-helix 1 and a b-strand (amino acids 43e66), with the C b atom pointing inwards. The G41R change is likely to destabilise the protein, since there is not enough room to accommodate the much larger Arg side chain. Even if the protein adjusted to make room for it, burial of the Arg positive charge would be highly destabilising. A similar scenario applied to BBS6 C99R, in the equatorial domain where introduction of a large positively charged Arg in the hydrophobic environment of the protein core would likely be destabilising. BBS10 L55P, predicted to be within an a-helix in the BBS10 model, is also likely a destabilising change as the introduction of a proline residue (a classical helix breaker) could affect the backbone structure and consequently helix packing in this region. L88 is predicted to be completely buried in the hydrophobic core of the equatorial domain of BBS12. The destabilising consequences of the mutant L88R would be similar to the BBS6 G41R change discussed above. For BBS12 G119S the effect on protein stability was difficult to predict, possibly less drastic. The mutation to a buried Ser residue might marginally affect protein stability, given the propensity of these residues to form H-bonds with the backbone of the neighbouring residue along the chain.
Genotypeephenotype correlation
Key systemic features are summarised in tables 2 and 4 while details of the ocular phenotype are listed in table 3. The MKKS phenotype was observed in patients with BBS10 and BBS12 mutations for the first time while the ALMS phenotype was associated with mutations in BBS1, 2, 6, 10 and 12. Several cases had features overlapping BBS, MKKS and ALMS phenotypes. The longitudinal information available suggested a trend of slower progression of vision loss with patients carrying BBS6 mutations when compared to those involving BBS10 or BBS12.
( figure 4, table 3) . Otherwise, the three groups of patients did not show any distinctive ocular or systemic phenotype. All patients had a retinal dystrophy with 88% of patients legally 
DISCUSSION
We provide the first comprehensive genotypeephenotype analysis of patients carrying mutations in the chaperonin-like BBS genes (BBS6, BBS10 and BBS12) and show that 36.5% of our BBS probands carry disease mutations in the chaperonin-like BBS genes. Sixty-eight per cent of changes identified were novel and most mutations were missense (60%), followed by insertion/ deletions (29%). Nonsense and silent mutations each accounted for 5% of the changes (table 1) . There was no correlation between phenotype severity and the type of mutations. Our genotyping results showed that BBS10 is the most frequently involved BBS locus (22% of BBS families), followed by BBS12 (9.5%) and BBS6 (5.4%). In our cohort, BBS12 mutations involved individuals of non-European ancestry, unlike those described by Stoetzel et al who were mostly Caucasian. 2 Mutations in BBS6 and BBS10 involved patients of diverse ethnic background. It has been shown that the apical domain of BBS6 may be required for BBS6 to target the centrosome. 11 The BBS6/MKKS A242S mutant, also located in the apical domain, has been shown to degrade rapidly before reaching the centrosome. 10 We observed A242S as a 'third allele' in cases 30 and 80 with no phenotype correlation observed. Two previously published recurrent BBS10 mutations were observed: C91LfsX5 and K243IfsX15. We saw the BBS10 C91LfsX5 variant in eight patients of European descent. The BBS10 K243IfsX15 variant previously identified by Stoetzel et al in Caucasian individuals was only observed here in black individuals of South African origin (table 1) .
The validation of pathogenicity potential of mutations used defined criteria and a number of useful bioinformatic tools. Figure 3 Segregation analysis of a Canadian native Indian (Dene) family affected with BBS and carrying novel mutations in BBS2, BBS4 and BBS12. Symbols are as for figure 2. Grey filling is unknown clinical status. [1] refers to BBS2 L125R, [2] refers to BBS4 E61K. and [3] refers to BBS12 R355Q. Protein modelling predicted destabilising consequences for five missense mutations found in the highly conserved structure of the N-terminal equatorial domains of BBS6, BBS10, BBS12 (figure 1). Although the sample size is limited, case 76 with mutation in the BBS6 apical domain (P299L) has a more severe visual impairment than cases 11 and 72 (table 3) with mutations in the highly conserved equatorial domain (G41R, C99R), predicted to destabilise the protein.
Sibs 65 and 66 were compound heterozygous for BBS10 L55P and a truncating mutation (E274VfsX29). These two sibs also carried a BBS12 missense variant (G119S, in cis with Y263H) that was also predicted to destabilise the protein. We could not assess whether the BBS12 variations influenced disease severity. Mutations in cis in either BBS10 or 12 were observed in more than one case (cases 60, 65 and 66, 2 and 3). A cis-acting pathogenic role of the second change could not be excluded. The phenotypes were severe in all cases and such cis variant interactions have been well described.
20e25
Of our 33 cases with a 'chaperonin-like' principal disease gene, 12 had more than two BBS mutant alleles documented. Half of these additional heterozygous changes involved a 'chaperoninlike' BBS gene (BBS6: 3, BBS12: 3). The incidence of a third mutant allele was higher than predicted by chance alone (12/33 (36%) vs 2%). 26 The biological significance of heterozygous changes was suggested by the previously reported signs of obligate carriers (obesity, high blood pressure) 27e30 and with the demonstration of interactions between a subset of BBS genes in zebra fish. The synergistic relationships between distinct combinations of mutants are thought to indicate specific interactions within a multi-subunit BBS complex. 31 In zebra fish embryos simultaneous suppression of all three 'chaperonin-like' genes resulted in a much more severe effect than individual morphants, suggesting a partial functional redundancy within this protein family. 2 Our study of the potential epistatic effect of these changes in our patients was limited by the sample sizes studied and variability in the phenotype information available, and was mostly anecdotal. This underscores the importance of comprehensive phenotyping of ciliopathies.
Obesity, digit anomaly and retinal dystrophy were highly penetrant traits for all patients.
In addition to the genetic complexity of patients affected with BBS, the range of clinical presentation showed overlap with other ciliopathies such as ALMS and MKKS. In our cohort, allelic variants of 'MKKS-like phenotype' were seen with mutations in BBS10 and BBS12 in addition to BBS6, suggesting this phenotype may be 'chaperonin-like' specific. On the contrary Alström-like phenotypes were associated with mutations in BBS1, BBS2, BBS6, BBS10 and BBS12 for the first time.
Although the visual impairment was variable, most were legally blind by the age of 18 years (88%). Natural history data showed that the disease worsened in the early teenage years. Visual function phenotype appeared to be worse in patients with BBS10 related disease, although this was only a trend. The visual function phenotype of our patients with mutations in BBS6, 10 or 12 was no different than that of patients with mutations in the BBSome related genes (data not shown). Four cases had ERG recordings documenting coneerod dystrophies in contrast to the more commonly seen rodecone dystrophy.
The ability to image the retinal findings (figure 4) was limited by patient cooperation and the intolerance of bright light. When available, retinal imaging showed non-specific changes consisting of mild pallor of the optic nerve with arteriolar attenuation and early changes in the macular area. Ocular coherence tomography (OCT) of the retina showed a thinning of the photoreceptor layer with preservation of the inner retina lamination ( figure 4) .
Although we present a significant amount of phenotype information, the ability to establish significant genotypee phenotype correlations was limited by sample size, phenotype complexity and its documentation. Nevertheless, we identified several cases with features of the phenotypes of MKKS and ALMS. The clinical and genetic overlaps between BBS related ciliopathies, the need for better genotypeephenotype correlations and better evaluation of the potential epistatic effect of additional mutations highlights the need for a revision of the diagnostic criteria and investigation protocols of BBS related ciliopathies.
Web resources
The URLs used for data presented are as follows: 
